Literature DB >> 24891167

Thyrotropin in the development and management of differentiated thyroid cancer.

Donald S A McLeod1.   

Abstract

Thyrotropin (TSH) is the major regulator and growth factor of the thyroid. TSH may be important in the development of human thyroid cancer, with both suggestive animal models and clinical evidence, although definitive proof is still required. Applications for TSH in thyroid cancer management include TSH stimulation of radioiodine uptake, enhancement of biochemical monitoring through thyroglobulin measurement, and long-term suppression of TSH with supraphysiologic levothyroxine. This review synthesizes current knowledge of TSH in both the development and management of differentiated thyroid cancer.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Recombinant human TSH; TSH; Thyroid cancer; Thyroid hormone; Thyrotropin

Mesh：

Substances：

Year:  2014        PMID： 24891167     DOI： 10.1016/j.ecl.2014.02.012

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  8 in total

1.  Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area?

Authors:  Kristine Zøylner Swan; Viveque Egsgaard Nielsen; Christian Godballe; Jens Faunø Thrane; Marie Riis Mortensen; Sten Schytte; Henrik Baymler Pedersen; Peer Christiansen; Steen Joop Bonnema
Journal:  Endocrine       Date:  2018-05-31       Impact factor: 3.633

Review 2.  Optimal differentiated thyroid cancer management in the elderly.

Authors:  Donald S A McLeod; Kelly Carruthers; Dev A S Kevat
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

3.  Papillary thyroid carcinoma presenting as a functioning thyroid nodule: report of 2 rare cases.

Authors:  Liang Hu; Yijun Wu
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

4.  Thyroid-Stimulating Hormone, Thyroid Hormones, and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study.

Authors:  Huang Huang; Jennifer Rusiecki; Nan Zhao; Yingtai Chen; Shuangge Ma; Herbert Yu; Mary H Ward; Robert Udelsman; Yawei Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-04-04       Impact factor: 4.254

Review 5.  Towards De-Implementation of low-value thyroid care in older adults.

Authors:  Jennifer M Perkins; Maria Papaleontiou
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-07-22       Impact factor: 3.626

Review 6.  Skeletal health in patients with differentiated thyroid carcinoma.

Authors:  M Cellini; M Rotondi; M L Tanda; E Piantanida; L Chiovato; P Beck-Peccoz; Andrea Lania; G Mazziotti
Journal:  J Endocrinol Invest       Date:  2020-07-21       Impact factor: 4.256

Review 7.  Female Reproductive Factors and Differentiated Thyroid Cancer.

Authors:  Mariacarla Moleti; Giacomo Sturniolo; Maria Di Mauro; Marco Russo; Francesco Vermiglio
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-23       Impact factor: 5.555

8.  Association between Iodine Intake, Thyroid Function, and Papillary Thyroid Cancer: A Case-Control Study.

Authors:  Kyungsik Kim; Sun Wook Cho; Young Joo Park; Kyu Eun Lee; Dong-Wook Lee; Sue K Park
Journal:  Endocrinol Metab (Seoul)       Date:  2021-08-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.